Industry News
Skin Protection From Ultraviolet Radiation Via Grape Compounds
Aug 01, 2011
Some compounds found in grapes help to protect skin cells from the sun's ultraviolet radiation, according to a study by researchers from the University of Barcelona and the CSIC (Spanish National Research Council). The study supports the use of grapes or grape derivatives in sun protection products... Read More
During Dialysis, Low Blood Pressure Found To Increase Risk Of Clots
Aug 01, 2011
A sudden drop in blood pressure while undergoing dialysis has long vexed many kidney patients. Side effects associated with this situation over the long term range from stroke to seizure to heart damage to death. Patients also suffer in the short term with gastrointestinal, muscular and neurologic symptoms. Now one more disturbing side effect can be been added to this list... Read More
Introducing Maspin Protein Into Tumor Nucleus Can Halt Growth And Spread
Jul 31, 2011
According to the Canadian Cancer Society, one in four Canadians will die of cancer. This year alone, the disease will kill an estimated 75,000 people. With incidence rates on the rise, more cancer patients are facing grave prognoses. Fortunately, Lawson Health Research Institute's Dr. John Lewis, Dr. Ann Chambers, and colleagues have found new hope for survival... Read More
Hot-Dog Health Warning Outside NASCAR Event In Indianapolis
Jul 30, 2011
A large billboard close to the Indianapolis Motor Speedway, that looks very similar in design to cigarette warnings, tells passers-by "Warning: Hot dogs can wreck your health." Readers are directed to CancerProject.org. The billboard has a picture of hotdogs sticking out of a cigarette pack, which has an image of the skull and crossbones... Read More
Inspiration Biopharmaceuticals Announces Data From OBI-1 Pivotal-Stage Program In Hemophilia At 23rd ISTH Congress
Jul 30, 2011
Inspiration Biopharmaceuticals, Inc. (Inspiration) announced data from its clinical development program for OBI-1, an intravenous (IV) recombinant porcine factor VIII product (rpFVIII), intended for the treatment of bleeding in people with hemophilia A with inhibitors and in people with acquired hemophilia... Read More
Being Brought Up In Livestock Farm Raises Risk Of Blood Cancers Later On
Jul 29, 2011
Individuals who were brought up in a livestock farm have a higher risk of developing blood cancers compared to other people, researchers from New Zealand and England reported in Occupational and Environmental Medicine, a BMJ publication. For those growing up in a poultry farm the risk was found to be three times higher... Read More
Male Circumcision Lowers Prevalence Of Penile Precancerous Lesions Among African Men
Jul 29, 2011
A University of North Carolina-led international study shows that among Kenyan men, circumcision is associated with a lower prevalence of human papillomavirus-associated precancerous lesions of the penis. Human papillomavirus HPV is a sexually transmitted virus that plays an important role in genital cancers in men and women, including cancers of the penis and cervix... Read More
System Developed At Wake Forest Baptist Helps Save Blood Through Real-Time Tracking Of Blood Bank Coolers
Jul 29, 2011
Human blood is a precious resource. Because stored blood has a very limited shelf life, keeping every available unit of it suitable for medical use is a crucial function at hospitals and other health care facilities especially during supply shortages such as those currently being experienced in the Triad, other parts of North Carolina and numerous sections of the country... Read More
Marshall Edwards Announces Publication Of Pre-Clinical Study Showing Activity In Chemotherapy-Resistant Ovarian Cancer Stem Cells
Jul 28, 2011
Marshall Edwards, Inc.(Nasdaq: MSHL), an oncology company focused on the clinical development of novel therapeutics targeting cancer metabolism, announced the publication of results from a pre-clinical study of NV-128 showing activity in chemotherapy-resistant ovarian cancer stem cells... Read More
Keryx Biopharmaceuticals Announces Completion Of Patient Enrollment In KRX-0401 (Perifosine) Phase 3 Refractory Advanced Colorectal Cancer Study
Jul 28, 2011
Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) announced completion of patient enrollment in its Phase 3 registration trial of KRX-0401 (perifosine) for the treatment of refractory, advanced colorectal cancer... Read More
Previous Page Next Page